Fosun Pharmaceutical 2196

Re: Fosun Pharmaceutical 2196

Postby winston » Thu Sep 10, 2020 9:01 am

vested

FOSUN PHARMA (02196.HK)'s Self-Developed COVID-19 Reagent Recognised by WHO

FOSUN PHARMA (02196.HK) announced that a novel coronavirus reagent (fluorescent PCR) developed by its subsidiary has been listed on the WHO's emergency list.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118527
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Mon Nov 09, 2020 11:12 pm

Pfizer Inc (N:PFE) on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against a pandemic that has killed over 1 million people, roiled the world's economy and upended daily life.

Pfizer and German partner BioNTech SE (O:BNTX) are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine.

The companies said they have so far found no serious safety concerns and expect to seek U.S. emergency use authorization later this month.

Source: investing.com
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118527
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Mon Oct 04, 2021 9:54 am

not vested

M Stanley Adds FOSUN PHARMA (02196.HK) TP to $61.3; Rated Equalweight

2021/09/08

Morgan Stanley ramped up the earnings forecasts for FOSUN PHARMA (02196.HK) , mainly on the back of the higher revenues from diagnostics and hospital services, and lower operating expense ratios.

Morgan Stanley hiked FOSUN PHARMA's target price from $56 to $61.3, with an Equalweight rating.

The broker remarked that FOSUN PHARMA's operations cover almost every segment in the Chinese medical and healthcare industry and is seeing consistent improvement on manufacturing pipeline with increasing R&D investment.

The market's demand for COVID-19 diagnosis and vaccine is likewise believed to drive FOSUN PHARMA's earnings performance, Morgan Stanley concluded.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118527
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Mon Oct 04, 2021 10:09 am

vested

BRIEF-Shanghai Fosun Pharmaceutical Plans To Sell Stake In Two Firms For 1.6 Bln Yuan

30 Sep 2021

Source: Reuters
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118527
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Mon Oct 04, 2021 9:11 pm

vested

FOSUN PHARMA (02196.HK) Interim NP Up 44.8% to RMB2.482B; Nil Div.

2021/08/24

FOSUN PHARMA (02196.HK) announced the interim results for the six months ended 30 June 2021.

The net profit for the period grew 44.8% YoY to RMB2.482 billion.

EPS was RMB97 fen.

No interim dividend was declared.

Dividend History
Announce Date Event Particular
2021/04/26 Quarter 1 No Dividend
2021/03/29 Final D:RMB 0.4300(equivalent to HKD 0.5200)
2020/10/29 Quarter 3 No Dividend
2020/08/25 Interim No Dividend

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118527
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Mon Oct 04, 2021 9:26 pm

not vested

July 21, 2021

Shanghai Fosun Pharmaceutical Group (2196 HK / 600196 CH) - Progress in regulatory process for its mRNA Covid-19 vaccine

Established in 1994, Shanghai Fosun Pharma is an integrated healthcare group in China offering pharmaceutical products, medical devices and healthcare services via its hospital network, and the healthcare arm of Fosun Group.

Its vision is to become a first tier enterprise in the global mainstream pharmaceutical and healthcare market.

Fosun’s pharmaceutical portfolio contributed ~72% of 2020 revenues, while other key contributing segments were medical devices and healthcare services.

In terms of geography, ~73% of its FY20 revenues was derived from China.

While Fosun provides medium term exposure to China’s growing demand for healthcare driven by increasing disposable income and aging population trends, near term factors which may influence share price performance include market expectations for pricing pressure from ongoing healthcare sector reforms and higher expenses relating to its R&D and growth plans .

HOLD (2196 HK) / SELL (600196 CH).

Source: OCBC
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118527
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Thu Oct 28, 2021 1:31 pm

vested

Shanghai Fosun Pharmaceutical Group (2196 HK / 600196 CH) - Softer 3Q margin

Established in 1994, Shanghai Fosun Pharma is an integrated healthcare group in China offering pharmaceutical products, medical devices and healthcare services via its hospital network, and the healthcare arm of Fosun Group.

Its vision is to become a first tier enterprise in the global mainstream pharmaceutical and healthcare market.

Fosun’s pharmaceutical portfolio contributed ~72% of 2020 revenues, while other key contributing segments were medical devices and healthcare services.

In terms of geography, ~73% of its FY20 revenues was derived from China.

While Fosun provides medium term exposure to China’s growing demand for healthcare driven by increasing disposable income and aging population trends, near term factors which may influence share price performance include market expectations for pricing pressure from ongoing healthcare sector reforms and higher expenses relating to its R&D and growth plans.

BUY (2196 HK) / HOLD (600196 CH).

Source: OCBC
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118527
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Wed Mar 23, 2022 1:41 pm

not vested

FOSUN PHARMA 2021 Net Profit RMB4.735B, Up 29%; Final DPS 56 Fen

FOSUN PHARMA (02196.HK) announced annual result ended December 2021.

The net profit amounted to RMB4.735 billion, up 29.3% YoY.

EPS was RMB1.85.

A final DPS of 56 fen was declared, against 43 fen in the corresponding period of the previous year.

Dividend History
Announce Date Event Particular
2021/10/26 Quarter 3 No Dividend
2021/08/23 Interim No Dividend
2021/04/26 Quarter 1 No Dividend
2021/03/29 Final D:RMB 0.4300(equivalent to HKD 0.5200)

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118527
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Wed Mar 23, 2022 1:43 pm

not vested

FOSUN PHARMA 2021 Asset Impairment Provisions Lead to RMB570M Reduction in NP

FOSUN PHARMA (02196.HK) announced that the total provisions for asset impairment of the group over the year of 2021 amounted to RMB612 million.

The provisions have led to a reduction of RMB612 million, RMB570 million and RMB570 million in the group's 2021 net profit, net profit attributable to the parent company and owner's equity attributable to shareholders of the listed company as at 31 December 2021, respectively.

Related News: FOSUN PHARMA 2021 Net Profit RMB4.735B, Up 29%; Final DPS 56 Fen

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118527
Joined: Wed May 07, 2008 9:28 am

Re: Fosun Pharmaceutical 2196

Postby winston » Thu Apr 14, 2022 10:45 am

not vested

FOSUN PHARMA's Covid Antigen Test Kit Approved for Commercialization in PRC

FOSUN PHARMA (02196.HK) announced that Fosun Diagnostic, a subsidiary of the Company, has received the registration approval issued by the National Medical Products Administration for the use of the Coronavirus Antigen Test Kit developed by Fosun Diagnostic.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118527
Joined: Wed May 07, 2008 9:28 am

PreviousNext

Return to D to K

Who is online

Users browsing this forum: No registered users and 6 guests